SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Marksans Pharma - Quaterly Results

12 Nov 2024 Evaluate
The Turnover for the quarter ended September 2024 of Rs. 3086.25 millions increase by 50.79% from Rs. 2046.73 millions.The Net Profit of the company vaulted to 102.00% to Rs. 632.04  millions from Rs. 312.89 millions in the previous quarter.The company reported a good operating profit of 836.29 millions compared to 532.30 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202409 202309 % Var 202409 202309 % Var 202403 202303 % Var
Sales 3086.25 2046.73 50.79 5631.52 3867.14 45.62 8532.73 6552.04 30.23
Other Income 313.57 159.31 96.83 395.09 485.54 -18.63 620.73 604.82 2.63
PBIDT 836.29 532.30 57.11 1330.47 1126.11 18.15 2020.08 1523.85 32.56
Interest 2.76 2.31 19.48 5.59 4.93 13.39 9.88 36.13 -72.65
PBDT 833.53 529.99 57.27 1324.88 1121.18 18.17 2010.20 1487.72 35.12
Depreciation 70.16 84.98 -17.44 138.52 132.22 4.76 291.28 167.37 74.03
PBT 763.37 445.01 71.54 1186.36 988.96 19.96 1718.92 1320.35 30.19
TAX 131.33 132.12 -0.60 234.17 234.16 0.00 381.34 291.69 30.73
Deferred Tax 5.22 15.36 -66.02 4.48 42.30 -89.41 6.78 -1.71 -496.49
PAT 632.04 312.89 102.00 952.19 754.80 26.15 1337.58 1028.66 30.03
Equity 453.16 453.16 0.00 453.16 453.16 0.00 453.16 45316.00 -99.00
PBIDTM(%) 27.10 26.01 4.19 23.63 29.12 -18.87 23.67 23.26 1.79

Marksans Pharma Share Price

180.50 1.60 (0.89%)
16-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1693.15
Dr. Reddys Lab 1221.25
Cipla 1230.75
Zydus Lifesciences 939.20
Lupin 2326.50
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×